A Randomized, Placebo-Controlled Study of Romosozumab for the Treatment of Hip Fractures

BACKGROUND: Romosozumab is a bone-forming antibody that increases bone formation and decreases bone resorption. We conducted a double-blinded, randomized, phase-2, dose-finding trial to evaluate the effect of romosozumab on the clinical outcomes of open reduction and internal fixation of intertrocha...

Descripción completa

Detalles Bibliográficos
Autores principales: Schemitsch, Emil H., Miclau, Theodore, Karachalios, Theofilos, Nowak, Lauren L., Sancheti, Parag, Poolman, Rudolf W., Caminis, John, Daizadeh, Nadia, Dent-Acosta, Ricardo E., Egbuna, Ogo, Chines, Arkadi, Maddox, Judy, Grauer, Andreas, Bhandari, Mohit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Journal of Bone and Joint Surgery, Inc. 2020
Materias:
Scientific Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7508283/
https://www.ncbi.nlm.nih.gov/pubmed/31977817
http://dx.doi.org/10.2106/JBJS.19.00790

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7508283/
https://www.ncbi.nlm.nih.gov/pubmed/31977817
http://dx.doi.org/10.2106/JBJS.19.00790

Ejemplares similares